NR and NMN are popular ways to try to boost levels of NAD+, but that approach hasn't worked every time in human studies. One reason for that may involve CD38, which degrades both NR and NMN. With the goal of boosting NAD+ levels during aging, why does CD38 increase with age, and what can be done about it?
CD38 gets in the way of NR and NMN for increasing NAD+
		 Started by 
	Michael Lustgarten
, Feb 02 2021 10:49 AM
	
	
		cd38 nad+ nmn aging longevity
		
	
		2 replies to this topic
	
	
#1
Posted 02 February 2021 - 10:49 AM
#2
Posted 02 February 2021 - 04:50 PM
Interesting connection with LPS and endotoxins. Thanks for sharing.
#3
Posted 02 February 2021 - 10:01 PM
There have been other threads discussing CD38 inhibition. Hopefully some more great information will also be shared in this thread.
Links to two of several:
https://www.longecit...ne/#entry847892
https://www.longecit...-consumer-cd38/
Edited by Heisok, 02 February 2021 - 10:01 PM.
Also tagged with one or more of these keywords: cd38, nad+, nmn, aging, longevity
		
		
		
		
		
		
			
				Science & Health   → 
			
				Lifestyle → 
			
				Nutrition → 
			
		
		
		Plate Challenge 2025Started by Cloomis , 30 Oct 2025  | 
	
	
		
  | 
	
		
	
  | 
	
||
		
		
		
		
		
		
			
				Science & Health   → 
			
				Lifestyle → 
			
				Nutrition → 
			
		
		
		Mediterranean Diet: The #1 Diet for 8 yearsStarted by Cloomis , 08 Oct 2025  | 
	
	
		
  | 
	
		
	
  | 
	
||
		
		
		
		
		
		
			
				Science & Health   → 
			
				Supplements → 
			
				NAD+ → 
			
		
		
		NMN Stands Apart From Other NAD+ PrecursorsStarted by ta5 , 05 Oct 2025  | 
	
	
		
  | 
	
		
	 
	
  | 
	
||
		
		
		
		
		
		
			
				Science & Health   → 
			
				Lifestyle → 
			
				Exercise → 
			
		
		
		The Food Pyramid is old news. Meet the new Exercise Pyramid.Started by Cloomis , 30 Sep 2025  | 
	
	
		
  | 
	
		
	
  | 
	
||
		
		
		
		
		
		
			
				Science & Health   → 
			
				AgingResearch → 
			
				Biomarkers & Genes → 
			
		
		
		Is Nicotinic Acid Bad For Longevity?Started by Michael Lustgarten , 21 Sep 2025  | 
	
	
		
  | 
	
		
	
  | 
	
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users



				
				
				
				
				
				
				
				
				
				
				
				
				
				
				
				
				
				
				
				
				
				
				

 
 
				
				
 








	